Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SABS, SABSW | SAB Biotherapeutics, Inc. | Director | $32.4M | Nov 24, 2023 | ||
PRVB | Provention Bio, Inc. | 10%+ Owner | Apr 27, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|